BPMC
Blueprint Medicines Corp
$90.61
Earnings Summary
Revenue | $71.96Mn |
Net Profits | $-110.92Mn |
Net Profit Margins | -154.14% |
Highlights
Blueprint Medicines Corp’s revenue jumped 85.55% since last year same period to $71.96Mn in the Q4 2023. On a quarterly growth basis, Blueprint Medicines Corp has generated 27.21% jump in its revenue since last 3-months.
Blueprint Medicines Corp’s net profit jumped 30.08% since last year same period to $-110.92Mn in the Q4 2023. On a quarterly growth basis, Blueprint Medicines Corp has generated 17.05% jump in its net profits since last 3-months.
Blueprint Medicines Corp’s net profit margin jumped 62.32% since last year same period to -154.14% in the Q4 2023. On a quarterly growth basis, Blueprint Medicines Corp has generated 34.79% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Blueprint Medicines Corp post its latest quarter earnings
EPS Estimate Current Quarter | -1.66 |
EPS Estimate Current Year | -1.66 |
Highlights
Blueprint Medicines Corp’s earning per share (EPS) estimates for the current quarter stand at -1.66 - a 18.63% jump from last quarter’s estimates.
Blueprint Medicines Corp’s earning per share (EPS) estimates for the current year stand at -1.66.
Key Ratios
Key ratios of the Blueprint Medicines Corp post its Q4 2023 earnings
Earning Per Share (EPS) | -1.82 |
Highlights
Blueprint Medicines Corp’s earning per share (EPS) jumped 31.32% since last year same period to -1.82 in the Q4 2023. This indicates that the Blueprint Medicines Corp has generated 31.32% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-15 | -2.04 | -1.82 | 10.78% |
2023-08-02 | -2.54 | -2.19 | 13.78% |
2023-05-04 | -2.67 | -2.15 | 19.48% |
2023-10-26 | -2.37 | -2.2 | 7.17% |
₹0 US Stocks a/c Opening Fee